Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility.
about
Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods.Genotoxicity of Superparamagnetic Iron Oxide Nanoparticles in Granulosa Cells.Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications.Facile preparation of multifunctional superparamagnetic PHBV microspheres containing SPIONs for biomedical applicationsA novel human artery model to assess the magnetic accumulation of SPIONs under flow conditions.Diverse Applications of Nanomedicine.Albumin corona on nanoparticles - a strategic approach in drug delivery.Impact of Superparamagnetic Iron Oxide Nanoparticles on Vocal Fold Fibroblasts: Cell Behavior and Cellular Iron KineticsTreatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.Velocity and displacement statistics in a stochastic model of nonlinear friction showing bounded particle speed.Design of Organic Macrocycle-Modified Iron Oxide Nanoparticles for Drug Delivery.Different storage conditions influence biocompatibility and physicochemical properties of iron oxide nanoparticlesTangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic Treatment.Tissue Plasminogen Activator Binding to Superparamagnetic Iron Oxide Nanoparticle-Covalent Versus Adsorptive Approach.Thermophoretically induced large-scale deformations around microscopic heat centers.The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.Shell matters: Magnetic targeting of SPIONs and in vitro effects on endothelial and monocytic cell functionInert Coats of Magnetic Nanoparticles Prevent Formation of Occlusive Intravascular Co-aggregates With Neutrophil Extracellular Traps
P2860
Q33596330-58AC44A3-2622-42EB-8E5A-8B9561ECA9BEQ35821937-57A3074F-90D1-4AAD-8F33-D0637B07DA25Q36324513-BE94B3AB-96CA-4E47-8DFC-33BC9AE79904Q36412229-B51EF571-DBC3-465B-B4CA-246857C427D7Q36719576-D5DD8368-B549-4792-B44D-FDA27D18D2E3Q37630470-34511E40-FCF7-4390-8D98-4E634D197C11Q37728142-8F867EF4-F3BD-42DC-A58D-3927AFBA0A49Q38521803-91274032-3D14-4038-BED7-5D3D18762B5CQ38692212-9EB5148E-C312-4127-9141-CCE5458537F5Q38830237-8306B6CE-4AFB-41CE-9A98-D93AE959FED2Q38891729-BB96CAC0-AB4B-440C-B4D5-2906028F411FQ38933734-A99E4D19-16D1-48BB-A64C-8178ECC7405BQ39121482-E27A0314-6C7E-43BE-B060-CDC8360D074DQ41876769-5352A465-B22E-4DBB-A082-8343E711938AQ41957148-973CB9A4-9A41-4828-B3A2-C586ACA8DBB8Q42109895-15EB0A45-186F-48FB-991C-DB15CAD0B6FCQ50645771-6F2B50DB-5632-4812-A9BE-1956A280DEB6Q51639424-80BA6F91-8522-43F0-BF13-FD792FEB0982Q57382895-9C5F8FE4-2640-4F7C-B53F-6D2548198E07Q58586414-B0F0975D-17DB-4415-832B-BE0EDB1CC931
P2860
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Development of a lauric acid/a ...... ith improved biocompatibility.
@en
Development of a lauric acid/a ...... ith improved biocompatibility.
@nl
type
label
Development of a lauric acid/a ...... ith improved biocompatibility.
@en
Development of a lauric acid/a ...... ith improved biocompatibility.
@nl
prefLabel
Development of a lauric acid/a ...... ith improved biocompatibility.
@en
Development of a lauric acid/a ...... ith improved biocompatibility.
@nl
P2093
P2860
P356
P1476
Development of a lauric acid/a ...... ith improved biocompatibility.
@en
P2093
Christina Janko
Christoph Alexiou
Dietmar Eberbeck
Frank Dörje
Geoffrey Lee
Harald Unterweger
Jan Zaloga
Jasmin Matuszak
Johannes Nowak
P2860
P304
P356
10.2147/IJN.S68539
P407
P50
P577
2014-10-20T00:00:00Z